世界のリンパ癌検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lymph Cancer Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4447 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、リンパ癌検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（核医療検査、血液検査、生検、その他）、用途別市場規模（病院、クリニック、がんセンター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・リンパ癌検査の市場動向 ・企業の競争状況、市場シェア ・リンパ癌検査の種類別市場規模と予測2016-2027（核医療検査、血液検査、生検、その他） ・リンパ癌検査の用途別市場規模と予測2016-2027（病院、クリニック、がんセンター） ・リンパ癌検査の北米市場規模2016-2027（アメリカ、カナダ） ・リンパ癌検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・リンパ癌検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リンパ癌検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・リンパ癌検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genomic Health、Bio Rad Laboratories、Siemens Healthcare、Abbott Laboratories、Canon Medical Systems、Agilent Technologies、MDx Health、Beckman Coulter、Myriad Genetics、Ambry Genetics） ・結論

Market Analysis and Insights: Global Lymph Cancer Testing Market
The global Lymph Cancer Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lymph Cancer Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lymph Cancer Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lymph Cancer Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lymph Cancer Testing market.

Global Lymph Cancer Testing Scope and Market Size
Lymph Cancer Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lymph Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nuclear Medical Tests
Blood Tests
Biopsy
Other

Segment by Application
Hospital
Clinic
Cancer Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genomic Health
Bio Rad Laboratories
Siemens Healthcare
Abbott Laboratories
Canon Medical Systems
Agilent Technologies
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lymph Cancer Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nuclear Medical Tests
1.2.3 Blood Tests
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Lymph Cancer Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Cancer Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lymph Cancer Testing Market Perspective (2016-2027)
2.2 Lymph Cancer Testing Growth Trends by Regions
2.2.1 Lymph Cancer Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lymph Cancer Testing Historic Market Share by Regions (2016-2021)
2.2.3 Lymph Cancer Testing Forecasted Market Size by Regions (2022-2027)
2.3 Lymph Cancer Testing Industry Dynamic
2.3.1 Lymph Cancer Testing Market Trends
2.3.2 Lymph Cancer Testing Market Drivers
2.3.3 Lymph Cancer Testing Market Challenges
2.3.4 Lymph Cancer Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lymph Cancer Testing Players by Revenue
3.1.1 Global Top Lymph Cancer Testing Players by Revenue (2016-2021)
3.1.2 Global Lymph Cancer Testing Revenue Market Share by Players (2016-2021)
3.2 Global Lymph Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lymph Cancer Testing Revenue
3.4 Global Lymph Cancer Testing Market Concentration Ratio
3.4.1 Global Lymph Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lymph Cancer Testing Revenue in 2020
3.5 Lymph Cancer Testing Key Players Head office and Area Served
3.6 Key Players Lymph Cancer Testing Product Solution and Service
3.7 Date of Enter into Lymph Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lymph Cancer Testing Breakdown Data by Type
4.1 Global Lymph Cancer Testing Historic Market Size by Type (2016-2021)
4.2 Global Lymph Cancer Testing Forecasted Market Size by Type (2022-2027)

5 Lymph Cancer Testing Breakdown Data by Application
5.1 Global Lymph Cancer Testing Historic Market Size by Application (2016-2021)
5.2 Global Lymph Cancer Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lymph Cancer Testing Market Size (2016-2027)
6.2 North America Lymph Cancer Testing Market Size by Type
6.2.1 North America Lymph Cancer Testing Market Size by Type (2016-2021)
6.2.2 North America Lymph Cancer Testing Market Size by Type (2022-2027)
6.2.3 North America Lymph Cancer Testing Market Size by Type (2016-2027)
6.3 North America Lymph Cancer Testing Market Size by Application
6.3.1 North America Lymph Cancer Testing Market Size by Application (2016-2021)
6.3.2 North America Lymph Cancer Testing Market Size by Application (2022-2027)
6.3.3 North America Lymph Cancer Testing Market Size by Application (2016-2027)
6.4 North America Lymph Cancer Testing Market Size by Country
6.4.1 North America Lymph Cancer Testing Market Size by Country (2016-2021)
6.4.2 North America Lymph Cancer Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lymph Cancer Testing Market Size (2016-2027)
7.2 Europe Lymph Cancer Testing Market Size by Type
7.2.1 Europe Lymph Cancer Testing Market Size by Type (2016-2021)
7.2.2 Europe Lymph Cancer Testing Market Size by Type (2022-2027)
7.2.3 Europe Lymph Cancer Testing Market Size by Type (2016-2027)
7.3 Europe Lymph Cancer Testing Market Size by Application
7.3.1 Europe Lymph Cancer Testing Market Size by Application (2016-2021)
7.3.2 Europe Lymph Cancer Testing Market Size by Application (2022-2027)
7.3.3 Europe Lymph Cancer Testing Market Size by Application (2016-2027)
7.4 Europe Lymph Cancer Testing Market Size by Country
7.4.1 Europe Lymph Cancer Testing Market Size by Country (2016-2021)
7.4.2 Europe Lymph Cancer Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lymph Cancer Testing Market Size (2016-2027)
8.2 Asia-Pacific Lymph Cancer Testing Market Size by Type
8.2.1 Asia-Pacific Lymph Cancer Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lymph Cancer Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lymph Cancer Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Lymph Cancer Testing Market Size by Application
8.3.1 Asia-Pacific Lymph Cancer Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lymph Cancer Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lymph Cancer Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Lymph Cancer Testing Market Size by Region
8.4.1 Asia-Pacific Lymph Cancer Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lymph Cancer Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lymph Cancer Testing Market Size (2016-2027)
9.2 Latin America Lymph Cancer Testing Market Size by Type
9.2.1 Latin America Lymph Cancer Testing Market Size by Type (2016-2021)
9.2.2 Latin America Lymph Cancer Testing Market Size by Type (2022-2027)
9.2.3 Latin America Lymph Cancer Testing Market Size by Type (2016-2027)
9.3 Latin America Lymph Cancer Testing Market Size by Application
9.3.1 Latin America Lymph Cancer Testing Market Size by Application (2016-2021)
9.3.2 Latin America Lymph Cancer Testing Market Size by Application (2022-2027)
9.3.3 Latin America Lymph Cancer Testing Market Size by Application (2016-2027)
9.4 Latin America Lymph Cancer Testing Market Size by Country
9.4.1 Latin America Lymph Cancer Testing Market Size by Country (2016-2021)
9.4.2 Latin America Lymph Cancer Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lymph Cancer Testing Market Size (2016-2027)
10.2 Middle East & Africa Lymph Cancer Testing Market Size by Type
10.2.1 Middle East & Africa Lymph Cancer Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lymph Cancer Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lymph Cancer Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Lymph Cancer Testing Market Size by Application
10.3.1 Middle East & Africa Lymph Cancer Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lymph Cancer Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lymph Cancer Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Lymph Cancer Testing Market Size by Country
10.4.1 Middle East & Africa Lymph Cancer Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lymph Cancer Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genomic Health
11.1.1 Genomic Health Company Details
11.1.2 Genomic Health Business Overview
11.1.3 Genomic Health Lymph Cancer Testing Introduction
11.1.4 Genomic Health Revenue in Lymph Cancer Testing Business (2016-2021)
11.1.5 Genomic Health Recent Development
11.2 Bio Rad Laboratories
11.2.1 Bio Rad Laboratories Company Details
11.2.2 Bio Rad Laboratories Business Overview
11.2.3 Bio Rad Laboratories Lymph Cancer Testing Introduction
11.2.4 Bio Rad Laboratories Revenue in Lymph Cancer Testing Business (2016-2021)
11.2.5 Bio Rad Laboratories Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Details
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Lymph Cancer Testing Introduction
11.3.4 Siemens Healthcare Revenue in Lymph Cancer Testing Business (2016-2021)
11.3.5 Siemens Healthcare Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Lymph Cancer Testing Introduction
11.4.4 Abbott Laboratories Revenue in Lymph Cancer Testing Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Canon Medical Systems
11.5.1 Canon Medical Systems Company Details
11.5.2 Canon Medical Systems Business Overview
11.5.3 Canon Medical Systems Lymph Cancer Testing Introduction
11.5.4 Canon Medical Systems Revenue in Lymph Cancer Testing Business (2016-2021)
11.5.5 Canon Medical Systems Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Lymph Cancer Testing Introduction
11.6.4 Agilent Technologies Revenue in Lymph Cancer Testing Business (2016-2021)
11.6.5 Agilent Technologies Recent Development
11.7 MDx Health
11.7.1 MDx Health Company Details
11.7.2 MDx Health Business Overview
11.7.3 MDx Health Lymph Cancer Testing Introduction
11.7.4 MDx Health Revenue in Lymph Cancer Testing Business (2016-2021)
11.7.5 MDx Health Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Lymph Cancer Testing Introduction
11.8.4 Beckman Coulter Revenue in Lymph Cancer Testing Business (2016-2021)
11.8.5 Beckman Coulter Recent Development
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Details
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Lymph Cancer Testing Introduction
11.9.4 Myriad Genetics Revenue in Lymph Cancer Testing Business (2016-2021)
11.9.5 Myriad Genetics Recent Development
11.10 Ambry Genetics
11.10.1 Ambry Genetics Company Details
11.10.2 Ambry Genetics Business Overview
11.10.3 Ambry Genetics Lymph Cancer Testing Introduction
11.10.4 Ambry Genetics Revenue in Lymph Cancer Testing Business (2016-2021)
11.10.5 Ambry Genetics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lymph Cancer Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nuclear Medical Tests
Table 3. Key Players of Blood Tests
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Lymph Cancer Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lymph Cancer Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lymph Cancer Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lymph Cancer Testing Market Share by Regions (2016-2021)
Table 10. Global Lymph Cancer Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lymph Cancer Testing Market Share by Regions (2022-2027)
Table 12. Lymph Cancer Testing Market Trends
Table 13. Lymph Cancer Testing Market Drivers
Table 14. Lymph Cancer Testing Market Challenges
Table 15. Lymph Cancer Testing Market Restraints
Table 16. Global Lymph Cancer Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lymph Cancer Testing Market Share by Players (2016-2021)
Table 18. Global Top Lymph Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymph Cancer Testing as of 2020)
Table 19. Ranking of Global Top Lymph Cancer Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lymph Cancer Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lymph Cancer Testing Product Solution and Service
Table 23. Date of Enter into Lymph Cancer Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lymph Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lymph Cancer Testing Revenue Market Share by Type (2016-2021)
Table 27. Global Lymph Cancer Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lymph Cancer Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lymph Cancer Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lymph Cancer Testing Revenue Market Share by Application (2016-2021)
Table 31. Global Lymph Cancer Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lymph Cancer Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lymph Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lymph Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lymph Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lymph Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lymph Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lymph Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lymph Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lymph Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lymph Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lymph Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lymph Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lymph Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lymph Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lymph Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lymph Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lymph Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lymph Cancer Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lymph Cancer Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lymph Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lymph Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lymph Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lymph Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lymph Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lymph Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lymph Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lymph Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lymph Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lymph Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lymph Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lymph Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Genomic Health Company Details
Table 64. Genomic Health Business Overview
Table 65. Genomic Health Lymph Cancer Testing Product
Table 66. Genomic Health Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 67. Genomic Health Recent Development
Table 68. Bio Rad Laboratories Company Details
Table 69. Bio Rad Laboratories Business Overview
Table 70. Bio Rad Laboratories Lymph Cancer Testing Product
Table 71. Bio Rad Laboratories Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 72. Bio Rad Laboratories Recent Development
Table 73. Siemens Healthcare Company Details
Table 74. Siemens Healthcare Business Overview
Table 75. Siemens Healthcare Lymph Cancer Testing Product
Table 76. Siemens Healthcare Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 77. Siemens Healthcare Recent Development
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Lymph Cancer Testing Product
Table 81. Abbott Laboratories Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 82. Abbott Laboratories Recent Development
Table 83. Canon Medical Systems Company Details
Table 84. Canon Medical Systems Business Overview
Table 85. Canon Medical Systems Lymph Cancer Testing Product
Table 86. Canon Medical Systems Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 87. Canon Medical Systems Recent Development
Table 88. Agilent Technologies Company Details
Table 89. Agilent Technologies Business Overview
Table 90. Agilent Technologies Lymph Cancer Testing Product
Table 91. Agilent Technologies Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 92. Agilent Technologies Recent Development
Table 93. MDx Health Company Details
Table 94. MDx Health Business Overview
Table 95. MDx Health Lymph Cancer Testing Product
Table 96. MDx Health Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 97. MDx Health Recent Development
Table 98. Beckman Coulter Company Details
Table 99. Beckman Coulter Business Overview
Table 100. Beckman Coulter Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 101. Beckman Coulter Recent Development
Table 102. Myriad Genetics Company Details
Table 103. Myriad Genetics Business Overview
Table 104. Myriad Genetics Lymph Cancer Testing Product
Table 105. Myriad Genetics Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 106. Myriad Genetics Recent Development
Table 107. Ambry Genetics Company Details
Table 108. Ambry Genetics Business Overview
Table 109. Ambry Genetics Lymph Cancer Testing Product
Table 110. Ambry Genetics Revenue in Lymph Cancer Testing Business (2016-2021) & (US$ Million)
Table 111. Ambry Genetics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lymph Cancer Testing Market Share by Type: 2020 VS 2027
Figure 2. Nuclear Medical Tests Features
Figure 3. Blood Tests Features
Figure 4. Biopsy Features
Figure 5. Other Features
Figure 6. Global Lymph Cancer Testing Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Cancer Center Case Studies
Figure 10. Lymph Cancer Testing Report Years Considered
Figure 11. Global Lymph Cancer Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lymph Cancer Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lymph Cancer Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global Lymph Cancer Testing Market Share by Regions (2022-2027)
Figure 15. Global Lymph Cancer Testing Market Share by Players in 2020
Figure 16. Global Top Lymph Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymph Cancer Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lymph Cancer Testing Revenue in 2020
Figure 18. Global Lymph Cancer Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global Lymph Cancer Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lymph Cancer Testing Market Share by Type (2016-2027)
Figure 22. North America Lymph Cancer Testing Market Share by Application (2016-2027)
Figure 23. North America Lymph Cancer Testing Market Share by Country (2016-2027)
Figure 24. United States Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lymph Cancer Testing Market Share by Type (2016-2027)
Figure 28. Europe Lymph Cancer Testing Market Share by Application (2016-2027)
Figure 29. Europe Lymph Cancer Testing Market Share by Country (2016-2027)
Figure 30. Germany Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lymph Cancer Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lymph Cancer Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lymph Cancer Testing Market Share by Region (2016-2027)
Figure 40. China Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lymph Cancer Testing Market Share by Type (2016-2027)
Figure 48. Latin America Lymph Cancer Testing Market Share by Application (2016-2027)
Figure 49. Latin America Lymph Cancer Testing Market Share by Country (2016-2027)
Figure 50. Mexico Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lymph Cancer Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lymph Cancer Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lymph Cancer Testing Market Share by Country (2016-2027)
Figure 56. Turkey Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lymph Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genomic Health Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 60. Bio Rad Laboratories Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 61. Siemens Healthcare Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 62. Abbott Laboratories Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 63. Canon Medical Systems Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 64. Agilent Technologies Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 65. MDx Health Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 66. Beckman Coulter Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 67. Myriad Genetics Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 68. Ambry Genetics Revenue Growth Rate in Lymph Cancer Testing Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---